Adrian Rawcliffe, CEO, Director at Adaptimmune Therapeutics, holds 44.85K shares in Adaptimmune Therapeutics (Ticker: ADAP), holds ― shares in Wave Life Sciences (Ticker: WVE).

See the Hottest Stocks Based on Insider Trading >

Adrian Rawcliffe
Adaptimmune Therapeutics (ADAP)
CEO, Director

Not Ranked

Adrian Rawcliffe has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ADAP

0.00%

WVE

A breakdown of Adrian Rawcliffe's holdings

See the Top Stocks by Insiders

Insider Roles

Adaptimmune Therapeutics
(ADAP)

CEO, Director

Wave Life Sciences
(WVE)

Director

Roles that Adrian Rawcliffe holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Adaptimmune Therapeutics
(ADAP)

Rating:Informative Sell

Date:Mar 22, 2018 - Mar 22, 2019

Return:+68.30%

The most profitable trade made by Adrian Rawcliffe

See the Latest Stocks Traded by Insiders

Adrian Rawcliffe's Trading History

ADAP

Adaptimmune Therapeutics

Jan 17, 2024

CEO, Director

Uninformative Sell

27.50K

$54.27K

WVE

Wave Life Sciences

―

Director

―

List of latest transactions for each holding click on a transaction to see Adrian Rawcliffe's performance on stock

See All Insider Trading from Today

Adrian Rawcliffe insider profile FAQ

What is the percentage of profitable transactions made by Adrian Rawcliffe?

The percentage of profitable transactions made by Adrian Rawcliffe is ―.

What is the average return per transaction made by Adrian Rawcliffe?

The average return per transaction made by Adrian Rawcliffe is ―.

What stocks does Adrian Rawcliffe hold?

Adrian Rawcliffe holds: ADAP, WVE stocks.

What was Adrian Rawcliffe’s latest transaction?

Adrian Rawcliffe latest transaction was an Uninformative Sell of $27.50K.

What was Adrian Rawcliffe's most profitable transaction?

Adrian Rawcliffe’s most profitable transaction was an Informative Sell of ADAP stock on March 22, 2018. The return on the trade was 68.30%.

What is Adrian Rawcliffe's role in Adaptimmune Therapeutics?

Adrian Rawcliffe's role in Adaptimmune Therapeutics is CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Adrian Rawcliffe Insider Profile

Adrian Rawcliffe Adaptimmune Therapeutics (ADAP)CEO, Director